Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Epimedium brevicornum
Species of Epimedium used in Korean and Japanese traditional medicine with slightly different phytochemical profile from E. grandiflorum. Key in Eastern Asian male tonic formulas.
Epimedium brevicornum, a species used in Korean and Japanese traditional medicine, is a key male tonic herb with a phytochemical profile distinct from E. grandiflorum. It is primarily used to support testosterone levels, bone health, and as an adaptogen, with active compounds including icariin, epimedin A, epimedin B, and sagittatoside.
Icariin, the primary active compound, acts as a phosphodiesterase-5 (PDE5) inhibitor, enhancing nitric oxide signaling and improving blood flow, which supports erectile function. It also upregulates testosterone synthesis via the cAMP/PKA pathway and stimulates osteoblast activity through BMP-2 and Runx2 signaling, promoting bone formation. Additionally, icariin exhibits anti-inflammatory effects by inhibiting NF-κB and COX-2 pathways, and adaptogenic properties via modulation of the HPA axis.
Species of Epimedium used in Korean and Japanese traditional medicine with slightly different phytochemical profile from E. grandiflorum. Key in Eastern Asian male tonic formulas.
Epimedium brevicornum, a species used in Korean and Japanese traditional medicine, is a key male tonic herb with a phytochemical profile distinct from E. grandiflorum. It is primarily used to support testosterone levels, bone health, and as an adaptogen, with active compounds including icariin, epimedin A, epimedin B, and sagittatoside.
Icariin, the primary active compound, acts as a phosphodiesterase-5 (PDE5) inhibitor, enhancing nitric oxide signaling and improving blood flow, which supports erectile function. It also upregulates testosterone synthesis via the cAMP/PKA pathway and stimulates osteoblast activity through BMP-2 and Runx2 signaling, promoting bone formation. Additionally, icariin exhibits anti-inflammatory effects by inhibiting NF-κB and COX-2 pathways, and adaptogenic properties via modulation of the HPA axis.